TY - JOUR
T1 - Occult Macular Dysfunction Syndrome
T2 - Identification of Multiple Pathologies in a Clinical Spectrum of Macular Dysfunction with Normal Fundus in East Asian Patients: EAOMD Report No. 5
AU - Fujinami-Yokokawa, Yu
AU - Yang, Lizhu
AU - Joo, Kwangsic
AU - Tsunoda, Kazushige
AU - Liu, Xiao
AU - Kondo, Mineo
AU - Ahn, Seong Joon
AU - Li, Hui
AU - Park, Kyu Hyung
AU - Tachimori, Hisateru
AU - Miyata, Hiroaki
AU - Woo, Se Joon
AU - Sui, Ruifang
AU - Fujinami, Kaoru
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/10
Y1 - 2023/10
N2 - Occult macular dystrophy (OMD) is the most prevalent form of macular dystrophy in East Asia. Beyond RP1L1, causative genes and mechanisms remain largely uncharacterised. This study aimed to delineate the clinical and genetic characteristics of OMD syndrome (OMDS). Patients clinically diagnosed with OMDS in Japan, South Korea, and China were enrolled. The inclusion criteria were as follows: (1) macular dysfunction and (2) normal fundus appearance. Comprehensive clinical evaluation and genetic assessment were performed to identify the disease-causing variants. Clinical parameters were compared among the genotype groups. Seventy-two patients with OMDS from fifty families were included. The causative genes were RP1L1 in forty-seven patients from thirty families (30/50, 60.0%), CRX in two patients from one family (1/50, 2.0%), GUCY2D in two patients from two families (2/50, 4.0%), and no genes were identified in twenty-one patients from seventeen families (17/50, 34.0%). Different severities were observed in terms of disease onset and the prognosis of visual acuity reduction. This multicentre large cohort study furthers our understanding of the phenotypic and genotypic spectra of patients with macular dystrophy and normal fundus. Evidently, OMDS encompasses multiple Mendelian retinal disorders, each representing unique pathologies that dictate their respective severity and prognostic patterns.
AB - Occult macular dystrophy (OMD) is the most prevalent form of macular dystrophy in East Asia. Beyond RP1L1, causative genes and mechanisms remain largely uncharacterised. This study aimed to delineate the clinical and genetic characteristics of OMD syndrome (OMDS). Patients clinically diagnosed with OMDS in Japan, South Korea, and China were enrolled. The inclusion criteria were as follows: (1) macular dysfunction and (2) normal fundus appearance. Comprehensive clinical evaluation and genetic assessment were performed to identify the disease-causing variants. Clinical parameters were compared among the genotype groups. Seventy-two patients with OMDS from fifty families were included. The causative genes were RP1L1 in forty-seven patients from thirty families (30/50, 60.0%), CRX in two patients from one family (1/50, 2.0%), GUCY2D in two patients from two families (2/50, 4.0%), and no genes were identified in twenty-one patients from seventeen families (17/50, 34.0%). Different severities were observed in terms of disease onset and the prognosis of visual acuity reduction. This multicentre large cohort study furthers our understanding of the phenotypic and genotypic spectra of patients with macular dystrophy and normal fundus. Evidently, OMDS encompasses multiple Mendelian retinal disorders, each representing unique pathologies that dictate their respective severity and prognostic patterns.
KW - CRX
KW - GUCY2D
KW - RP1L1
KW - miyake disease
KW - non-RP1L1
KW - occult macular dystrophy
UR - http://www.scopus.com/inward/record.url?scp=85175278133&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85175278133&partnerID=8YFLogxK
U2 - 10.3390/genes14101869
DO - 10.3390/genes14101869
M3 - Article
C2 - 37895218
AN - SCOPUS:85175278133
SN - 2073-4425
VL - 14
JO - Genes
JF - Genes
IS - 10
M1 - 1869
ER -